MiR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 753-760

  Liu, Lipeng ^a   Yu, Xiaohua ^b   Guo, Xiaofang ^a   Tian, Zhi ^a   Su, Min ^a   Long, Yu ^a   Huang, Chunxia ^a   Zhou, Feng ^a   Liu, Meiling ^a   Wu, Xinhua ^c   Wang, Xiaochun ^d  

^a CHANGSHA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; HeLa; MiR 143; Proliferation

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 143; PROTEIN BCL 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; UTERINE CERVIX CANCER;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; DOWN-REGULATION; FEMALE; HELA CELLS; HUMANS; MICE; MICE, NUDE; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSPLANTATION, HETEROLOGOUS; UTERINE CERVICAL NEOPLASMS;

MUS MUSCULUS;

EID: 84863011861     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.696     Document Type: Article

References (29)

1. Meng F, Henson R, Wehbe-Janek H, et al: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007. (Pubitemid 47187346)
2. Cordes KR, Sheehy NT, White MP, et al: miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710, 2009.
3. Tang F, Kaneda M, O'Carroll D, et al: Maternal microRNAs are essential for mouse zygotic development. Genes Dev 21: 644-648, 2007. (Pubitemid 46440286)
4. Davidson MR, Larsen JE, Yang IA, et al: MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One 5: e12560, 2010.
5. Giovannetti E, Funel N, Peters GJ, et al: MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 70: 4528-4538, 2010.
6. Hu G, Chen D, Li X, et al: miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther 10: 190-197, 2010.
7. Motoyama K, Inoue H, Mimori K, et al: Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol 36: 1089-1095, 2010.
8. Wickramasinghe NS, Manavalan TT, Dougherty SM, et al: Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37: 2584-2595, 2009.
9. Su H, Yang JR, Xu T, et al: MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135-1142, 2009.
10. Liu X, Sempere LF, Galimberti F, et al: Uncovering growth-suppressive microRNAs in lung cancer. Clin Cancer Res 15: 1177-1183, 2009.
11. Sengupta S, den Boon JA, Chen IH, et al: MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 105: 5874-5878, 2008. (Pubitemid 351758465)
12. Wang X, Tang S, Le SY, et al: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557, 2008.
13. Martinez I, Gardiner AS, Board KF, et al: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582, 2008. (Pubitemid 351550884)
14. Borralho PM, Kren BT, Castro RE, et al: MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J 276: 6689-6700, 2009.
15. Kulda V, Pesta M, Topolcan O, et al: Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 200: 154-160, 2010.
16. Gao W, Yu Y, Cao H, et al: Deregulated expression of miR-21, miR-143 and miR-181a in non-small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 64: 399-408, 2010.
17. Szczyrba J, Löprich E, Wach S, et al: The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 8: 529-538, 2010.
18. Zhang X, Liu S, Hu T, et al: Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50: 490-499, 2009.
19. Clapé C, Fritz V, Henriquet C, et al: miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 4: e7542, 2009.
20. Ng EK, Tsang WP, Ng SS, et al: MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706, 2009.
21. Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297, 2005. (Pubitemid 41439922)
22. Yang Z, Chen S, Luan X, et al: MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 61: 1075-1082, 2009.
23. Pang RT, Leung CO, Ye TM, et al: MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 31: 1037-1044, 2010.
24. Zhang H, Cai X, Wang Y, et al: microRNA-143, downregulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24: 1363-1369, 2010.
25. Pillai MR, Halabi S, McKalip A, et al: The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 5: 329-335, 1996. (Pubitemid 26139114)
26. Dimitrakakis C, Kymionis G, Diakomanolis E, et al: The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol Oncol 77: 129-136, 2000. (Pubitemid 30217316)
27. Xiong Y, Fang JH, Yun JP, et al: Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836-845, 2010.
28. Chen G, Zhu W, Shi D, et al: microRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep 23: 997-1003, 2010.
29. Xia L, Zhang D, Du R, et al: miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379, 2008. (Pubitemid 351842022)